Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 8 November 1985:
Vol. 230. no. 4726, pp. 681 - 683
DOI: 10.1126/science.2996146
Prev | Table of Contents | Next

Articles

Science, Vol 230, Issue 4726, 681-683
Copyright © 1985 by American Association for the Advancement of Science

articles

Hypoglycemia-induced neuronal damage prevented by an N-methyl-D-aspartate antagonist

T Wieloch

The possibility that neuronal damage due to hypoglycemia is induced by agonists acting on the N-methyl-D-aspartate (NMDA) receptor was investigated in the rat caudate nucleus. Local injections of an NMDA receptor antagonist, 2-amino-7-phosphonoheptanoic acid, were performed before induction of 30 minutes of reversible, insulin-induced, hypoglycemic coma. Neuronal necrosis in these animals after 1 week of recovery was reduced 90 percent compared to that in saline-injected animals. The results suggest that hypoglycemic neuronal damage is induced by NMDA receptor agonists, such as the excitatory amino acids or related compounds.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Neuronal functions, feeding behavior, and energy balance in Slc2a3+/- mice.
S. Schmidt, M. Richter, D. Montag, T. Sartorius, V. Gawlik, A. M. Hennige, S. Scherneck, H. Himmelbauer, S. Z. Lutz, R. Augustin, et al. (2008)
Am J Physiol Endocrinol Metab 295, E1084-E1094
   Abstract »    Full Text »    PDF »
Patterns of Cerebral Injury and Neurodevelopmental Outcomes After Symptomatic Neonatal Hypoglycemia.
C. M. Burns, M. A. Rutherford, J. P. Boardman, and F. M. Cowan (2008)
Pediatrics 122, 65-74
   Abstract »    Full Text »    PDF »
Cognitive Dysfunction and Diabetes Mellitus.
C. T. Kodl and E. R. Seaquist (2008)
Endocr. Rev. 29, 494-511
   Abstract »    Full Text »    PDF »
Pyruvate Administered After Severe Hypoglycemia Reduces Neuronal Death and Cognitive Impairment.
S. W. Suh, K. Aoyama, Y. Matsumori, J. Liu, and R. A. Swanson (2005)
Diabetes 54, 1452-1458
   Abstract »    Full Text »    PDF »
Protein-Protein Coupling/Uncoupling Enables Dopamine D2 Receptor Regulation of AMPA Receptor-Mediated Excitotoxicity.
S. Zou, L. Li, L. Pei, B. Vukusic, H. H. M. Van Tol, F. J. S. Lee, Q. Wan, and F. Liu (2005)
J. Neurosci. 25, 4385-4395
   Abstract »    Full Text »    PDF »
Under-recognised paradox of neuropathy from rapid glycaemic control.
M K S Leow and J Wyckoff (2005)
Postgrad. Med. J. 81, 103-107
   Abstract »    Full Text »    PDF »
Hypoglycemic Neuronal Death and Cognitive Impairment Are Prevented by Poly(ADP-Ribose) Polymerase Inhibitors Administered after Hypoglycemia.
S. W. Suh, K. Aoyama, Y. Chen, P. Garnier, Y. Matsumori, E. Gum, J. Liu, and R. A. Swanson (2003)
J. Neurosci. 23, 10681-10690
   Abstract »    Full Text »    PDF »
Molecular Switches Deciding the Death of Injured Neurons.
P. Nicotera (2003)
Toxicol. Sci. 74, 4-9
   Abstract »    Full Text »    PDF »
NMDA Receptor Antagonists Disinhibit Rat Posterior Cingulate and Retrosplenial Cortices: A Potential Mechanism of Neurotoxicity.
Q. Li, S. Clark, D. V. Lewis, and W. A. Wilson (2002)
J. Neurosci. 22, 3070-3080
   Abstract »    Full Text »    PDF »
Post-ischaemic long-term synaptic potentiation in the striatum: a putative mechanism for cell type-specific vulnerability.
P. Calabresi, E. Saulle, D. Centonze, A. Pisani, G. A. Marfia, and G. Bernardi (2002)
Brain 125, 844-860
   Abstract »    Full Text »    PDF »
Interleukin-10 Prevents Glutamate-Mediated Cerebellar Granule Cell Death by Blocking Caspase-3-Like Activity.
A. Bachis, A. M. Colangelo, S. Vicini, P. P. Doe, M. A. De Bernardi, G. Brooker, and I. Mocchetti (2001)
J. Neurosci. 21, 3104-3112
   Abstract »    Full Text »    PDF »
Neuroprotective Effect of High Glucose Against NMDA, Free Radical, and Oxygen-Glucose Deprivation through Enhanced Mitochondrial Potentials.
S. Y. Seo, E. Y. Kim, H. Kim, and B. J. Gwag (1999)
J. Neurosci. 19, 8849-8855
   Abstract »    Full Text »    PDF »
Activity-dependent Release of Brain-derived Neurotrophic Factor Underlies the Neuroprotective Effect of N-Methyl-D-aspartate.
A. M. Marini, S. J. Rabin, R. H. Lipsky, and I. Mocchetti (1998)
J. Biol. Chem. 273, 29394-29399
   Abstract »    Full Text »    PDF »
Brain-Derived Neurotrophic Factor and Basic Fibroblast Growth Factor Downregulate NMDA Receptor Function in Cerebellar Granule Cells.
C. Brandoli, A. Sanna, M. A. De Bernardi, P. Follesa, G. Brooker, and I. Mocchetti (1998)
J. Neurosci. 18, 7953-7961
   Abstract »    Full Text »    PDF »
High Affinity Glutamate Transporters: Regulation of Expression and Activity.
G. Gegelashvili and A. Schousboe (1997)
Mol. Pharmacol. 52, 6-15
   Abstract »    Full Text »
Secondary Activation of a Cation Conductance Is Responsible for NMDA Toxicity in Acutely Isolated Hippocampal Neurons.
Q. X. Chen, K. L. Perkins, D. W. Choi, and R. K. S. Wong (1997)
J. Neurosci. 17, 4032-4036
   Abstract »    Full Text »    PDF »
Opposite Membrane Potential Changes Induced by Glucose Deprivation in Striatal Spiny Neurons and in Large Aspiny Interneurons.
P. Calabresi, C. M. Ascone, D. Centonze, A. Pisani, G. Sancesario, V. D'Angelo, and G. Bernardi (1997)
J. Neurosci. 17, 1940-1949
   Abstract »    Full Text »    PDF »
N-Methyl-D-aspartate Antagonist Activity of alpha - and beta -Sulfallorphans.
V. K. Shukla and S. Lemaire (1997)
J. Pharmacol. Exp. Ther. 280, 357-365
   Abstract »    Full Text »
Severe Transient Hypoglycemia Causes Reversible Change in the Apparent Diffusion Coefficient of Water.
Y. Hasegawa, J. E. Formato, L. L. Latour, J. A. Gutierrez, K.-F. Liu, J. H. Garcia, C. H. Sotak, M. Fisher, and J. E. Brayden (1996)
Stroke 27, 1648-1656
   Abstract »    Full Text »
The calcium channel blocker nifedipine attenuates slow excitatory amino acid neurotoxicity.
J. Weiss, D. Hartley, J Koh, and D. Choi (1990)
Science 247, 1474-1477
   Abstract »    PDF »
Glutamate, a Neurotoxic Transmitter.
J. W. Olney (1989)
J Child Neurol 4, 218-226
   PDF »
Selective Vulnerability of the Brain: New Insights into the Pathophysiology of Stroke.
R. C. Collins, B. H. Dobkin, and D. W. Choi (1989)
Ann Intern Med 110, 992-1000
   Abstract »    PDF »
The role of excitatory amino acids and NMDA receptors in traumatic brain injury.
A. Faden, P Demediuk, S. Panter, and R Vink (1989)
Science 244, 798-800
   Abstract »    PDF »
Indole-2-carboxylic acid: a competitive antagonist of potentiation by glycine at the NMDA receptor.
J. Huettner (1989)
Science 243, 1611-1613
   Abstract »    PDF »
Role for excitatory amino acids in methamphetamine-induced nigrostriatal dopaminergic toxicity.
P. Sonsalla, W. Nicklas, and R. Heikkila (1989)
Science 243, 398-400
   Abstract »    PDF »
Glutamate Antagonist Therapy Reduces Neurologic Deficits Produced by Focal Central Nervous System Ischemia.
A. Kochhar, J. A. Zivin, P. D. Lyden, and V. Mazzarella (1988)
Arch Neurol 45, 148-153
   Abstract »    PDF »
Zinc selectively blocks the action of N-methyl-D-aspartate on cortical neurons.
S Peters, J Koh, and D. Choi (1987)
Science 236, 589-593
   Abstract »    PDF »
Delayed transneuronal death of substantia nigra neurons prevented by gamma-aminobutyric acid agonist.
M Saji and D. Reis (1987)
Science 235, 66-69
   Abstract »    PDF »
Neurons containing NADPH-diaphorase are selectively resistant to quinolinate toxicity.
J. Koh, S Peters, and D. Choi (1986)
Science 234, 73-76
   Abstract »    PDF »
The Role of Glutamate in Neurotransmission and in Neurologic Disease.
J. T. Greenamyre (1986)
Arch Neurol 43, 1058-1063
   Abstract »    PDF »
The Protein-tyrosine Phosphatase PTPMEG Interacts with Glutamate Receptor delta 2 and epsilon Subunits.
K. Hironaka, H. Umemori, T. Tezuka, M. Mishina, and T. Yamamoto (2000)
J. Biol. Chem. 275, 16167-16173
   Abstract »    Full Text »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)